New program aims to help HIV/TB patients kick the habit
NCT ID NCT05842161
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new program called QUIT-AD to help people living with HIV or tuberculosis (TB) in Cape Town, South Africa, quit smoking. The program combines proven methods to support smoking cessation and improve HIV/TB treatment results. Researchers will enroll 86 daily smokers to see if the program is practical, well-liked, and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Cape Town
RECRUITINGRondebosch, 7700, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo break the smoking habit?
- Personalized nicotine patch dosing may boost quit rates
- Can a plasma beam stop anal lesions from becoming cancer?
- Talking it out: could a Conversation-Based approach curb smoking in future nurses?
- A stronger nicotine patch might break the dual Smoking-Vaping habit
- Free meds could boost quit rates in stroke survivors